
We know scientists have busy schedules. 🤷 That's why we put together #ProstateCell News, an online publication and bi-weekly email newsletter covering the latest research into breast cancer and mammary cells. 📰 Subscribe here: bit.ly/4kkWMEu

An online resource for researchers studying prostate cells and prostate cancer. Part of the @STEMCELLTech Science News service.

We know scientists have busy schedules. 🤷 That's why we put together #ProstateCell News, an online publication and bi-weekly email newsletter covering the latest research into breast cancer and mammary cells. 📰 Subscribe here: bit.ly/4kkWMEu

🚨 New in @cddpress!🚨 💡 Novel mechanisms of resistance to cell cycle blockade revealed. 💡 Potential adaptations for intervention with therapeutics that induce cell cycle arrest in #ProstateCancer highlighted. Read the paper📝 go.nature.com/4iIvhGp

🚨 #NewResearch alert! 🚨 @UMich researchers describe a novel therapeutic modality, domain-alteration chimeras, and support its translational potential in androgen receptor-driven #ProstateCancer. Read the #OpenAccess article in @Nature 👉 go.nature.com/3UQxIO0

🥼 Researchers developed a personalized nanotechnology-enabled dual neurotherapy for #ProstateCancer that employs hybrid nanovesicles to codeliver a β-blocker and muscarinic receptor antagonist to autonomic nerves in residual tumor! Read more: bit.ly/3VieL71.

This review finds that acid phosphatase (ACP) 3 functions as a favorable prognostic biomarker, whereas ACP1 acts as a potential negative prognostic indicator in #ProstateCancer. 📝 #OpenAccess (@BJUIjournal) | bit.ly/4iuzKMU

By interacting with FLOT2 and suppressing the STAT3/IDO1/TRP metabolism axis, Hyperoside (HYP) induces #ferroptosis in #ProstateCancer: 💡This supports the potential of HYP as a promising natural therapeutic candidate! Read the paper | bit.ly/4yZKkQG

Researchers conducted a study to determine the optimal preparation conditions of cabazitaxel encapsulated in polycaprolactone polymeric nanoparticles functionalized with transferrin, in terms of formulation characteristics for the treatment of #ProstateCancer. Read the #OpenAccess paper👉 bit.ly/4iy4sn6

💡 In this @ScienceAdvances article, @UNI_FIRENZE researchers identify #LacticAcid, a highly abundant environmental metabolite at the primary site in #ProstateCancer, as a key inducer of dormant state, associated with stemness, therapy tolerance, and invasiveness. 🔗 bit.ly/4dZ4jYo

New in @NatureComms: Researchers uncovered the full spectrum and recurrence patterns of genomic driver alterations in primary #ProstateCancers and delivered targets for biomarker development, mechanistic studies, and potential therapeutic interventions. Congratulations to first authors Diogo Pellegrina of @OICR_news, Daria Kiriy (@DKiriy) of University of Copenhagen, and Kevin Cheng of @UofT, as well as their colleagues! Read the #OpenAccess paper | go.nature.com/4Bvw1G9

This study demonstrated that leucine-rich repeat-containing G protein-coupled receptor 4 was overexpressed in #BenignProstaticHyperplasia and localized within the stromal and epithelial components of the prostate. Learn more: bit.ly/4zFPVwu

By exploring emerging frontiers including neuroendocrine transdifferentiation, #nanobiotechnology, and liquid biopsy, this review proposes a roadmap for next-generation therapies aimed at sensitizing #ProstateCancer to immune recognition. 🗺️ Give it a read: bit.ly/3VMFZCN

Scientists dissect the multidimensional resistance mechanisms of #ProstateCancer to immune checkpoint inhibitors, ranging from myeloid cell plasticity to stromal stiffening. 📄 Abstract: bit.ly/3VMFZCN

💡 Transient receptor potential melastatin 4 (TRPM4) is a mechanistic driver and predictive biomarker of Acetalax response in prostate cancer 💡 A rationale for the clinical development of Acetalax for TRPM4-expressing and treatment-refractory prostate cancer is provided Read more: bit.ly/47TEtRR #ProstateCancer #CancerResearch

New in @CommsMedicine: study findings (@ucl and @UCLMS) highlight limitations in the representativeness of widely used #ProstateCancer cell lines and emphasize the importance of selecting models according to their clinical and molecular relevance. #OpenAccess 🔗 go.nature.com/4zyz26U

New study findings from researchers at @NotreDame identify PYGO2 as a #tumor-intrinsic regulator of castration resistance and antitumor #immunity in #ProstateCancer. 🔗 bit.ly/3VFHpPi

📢 Research in @iScience_CP investigated how physiologically relevant mechanical properties affect prostate cancer cells, demonstrating that mechanical microenvironmental cues substantially shape prostate cancer cell phenotypes. 🔗 bit.ly/4yuWEZP #ProstateCancer #OpenAccess